Low-Level Light Therapy for Post-Training Recovery - Quick Reference Sheet
evipedia.ai ← Back

Low-Level Light Therapy for Post-Training Recovery

Created on 08/10/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Red and near-infrared light over working muscles is a low-effort, low-hazard training addition with real but narrow benefits: less soreness, smaller rises in blood markers of muscle damage, longer work capacity, faster return of strength. Effects are most reliable when light is applied shortly before the session. Maximal strength, sprinting and full-body cabins are unsupported. (Full Review)

Protocol

Pre-exercise application
5–10 min before training
This timing has the strongest pooled support; post-exercise within 30–60 minutes shows smaller effects on performance outcomes.
Energy dosing
20–60 J small, 60–300 J large
Total joules per muscle group, from emitters of no more than about 200 mW each, spread across multiple points over the muscle belly.
Wavelength selection
655–950 nm
Red at 630–660 nm is absorbed more superficially; near-infrared at 800–850 nm penetrates further and is preferred for muscle bellies under subcutaneous fat.
Time to effect
Soreness
24–96 hours
Acute outcomes appear within a single session, measurable after the first treated bout.
Muscle damage markers
24–96 hours
Smaller enzyme rises are measurable after the first treated bout.
Training adaptation
8+ weeks
Any effect on training adaptation, if it exists, requires a block of at least 8 weeks to become visible.

Benefits

Contraindications
  • Photodynamic therapy agents (5-aminolevulinic acid, methyl aminolevulinate, porfimer sodium) within the clearance window (typically 4–6 weeks for porfimer sodium)
  • Known or suspected malignancy in the treatment field
  • Over the uterus in pregnancy
  • Over the anterior neck with active thyroid disease
  • Over an implanted photosensitive device, or an active epiphyseal growth plate in skeletally immature athletes
  • Porphyria, or systemic lupus erythematosus with active cutaneous involvement
  • Within 6 months of intraocular surgery, when laser-class emitters are used near the head
    •
Key Interactions
  • Photosensitising prescription drugs: tetracyclines (doxycycline, minocycline), fluoroquinolones (ciprofloxacin, levofloxacin), oral retinoids (isotretinoin, acitretin), thiazide diuretics (hydrochlorothiazide), amiodarone, phenothiazines (chlorpromazine)
  • Over-the-counter medications: non-steroidal anti-inflammatory drugs (ibuprofen, naproxen), topical retinoids and alpha-hydroxy acid preparations, oral antihistamines (diphenhydramine)
  • Supplement interactions: St John's wort (hypericin), high-dose antioxidants (vitamin C above roughly 1 g daily with vitamin E above 400 IU daily, N-acetylcysteine)
  • Supplements with additive effects: creatine monohydrate, tart cherry concentrate, omega-3 fatty acids, melatonin with evening whole-body exposure
  • Other intervention interactions: cold-water immersion to the same muscle in the same session, heat exposure, sauna, massage, systemic corticosteroids

Risk & Side Effects

  • High: Retinal injury from direct beam exposure; transient local warmth and erythema
  • Medium: Photosensitivity reactions with photosensitising agents; post-inflammatory hyperpigmentation in darker skin; thermal burns from high-output or contact devices
  • Low: Blunting of training adaptation through suppressed redox signalling; loss of effect from overdosing; masking of injury signals
  • Speculative: Stimulation of undiagnosed malignant or pre-malignant lesions; endocrine effects from anterior neck irradiation

Monitoring

Marker Target Why
Creatine Kinase (CK) Resting 60–200 U/L; post-session rise under 3× own resting value The standard objective index of muscle fibre membrane disruption, and the outcome with the most consistent pooled response
Lactate Dehydrogenase (LDH) 140–200 U/L at rest A second, slower-clearing marker of cell membrane stress that cross-checks the creatine kinase signal
High-Sensitivity C-Reactive Protein (hs-CRP) Below 0.8 mg/L for an athletic population Captures the systemic inflammatory load the intervention is proposed to reduce, and flags accumulated training stress
Testosterone-to-Cortisol Ratio Within 30% of own established baseline Distinguishes genuine recovery improvement from accumulating overreaching that the intervention cannot fix
Ferritin 40–100 ng/mL, read alongside hs-CRP Low iron stores produce fatigue and poor recovery that no light protocol will address, and are common in endurance-trained women

Cadence: Baseline resting values during a normal training week; repeated 24 hours after a standardised damaging session at the end of an untreated block and again at the end of a treated block; then annually where the intervention becomes routine.

Qualitative Assessment

  • Soreness rating on a fixed 0–10 scale
  • Repetitions completed at a fixed load
  • Session rating of perceived exertion
  • Sleep quality and total sleep time
  • Waking resting heart rate and heart rate variability
  • Subjective readiness to train
  • Skin appearance over the treated area at 24 and 48 hours
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.